(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help prevent further damage to the airways.

The American Lung Association, with support from Boehringer Ingelheim, is raising awareness about the need for early diagnosis and treatment of bronchiectasis. Here are the top things to know:

Bronchiectasis is chronic. Bronchiectasis is a lifelong, progressive lung condition where the walls of your airways (bronchi) are permanently damaged, becoming widened and thickened from inflammation and infection. Getting the correct treatment as early as possible can help improve health outcomes and quality of life.

Diagnosis is often delayed. Two of bronchiectasis’s hallm

See Full Page